104 related articles for article (PubMed ID: 37425866)
1. RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential.
Van Espen B; Oo HZ; Collins C; Fazli L; Molinolo A; Murad R; Gleave M; Ronai ZA
bioRxiv; 2023 Jul; ():. PubMed ID: 37425866
[TBL] [Abstract][Full Text] [Related]
2. RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential.
Van Espen B; Oo HZ; Collins C; Fazli L; Molinolo A; Yip K; Murad R; Gleave M; Ronai ZA
Mol Cancer Res; 2024 Jan; 22(1):41-54. PubMed ID: 37831068
[TBL] [Abstract][Full Text] [Related]
3. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Liu D; Zhang M; Song Y; Yang N
Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519
[TBL] [Abstract][Full Text] [Related]
4. RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis.
Qiu D; Wang Q; Wang Z; Chen J; Yan D; Zhou Y; Li A; Zhang R; Wang S; Zhou J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1552-1561. PubMed ID: 29481911
[TBL] [Abstract][Full Text] [Related]
5. RNF185 is a novel E3 ligase of endoplasmic reticulum-associated degradation (ERAD) that targets cystic fibrosis transmembrane conductance regulator (CFTR).
El Khouri E; Le Pavec G; Toledano MB; Delaunay-Moisan A
J Biol Chem; 2013 Oct; 288(43):31177-91. PubMed ID: 24019521
[TBL] [Abstract][Full Text] [Related]
6. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
7. RNF185, a novel mitochondrial ubiquitin E3 ligase, regulates autophagy through interaction with BNIP1.
Tang F; Wang B; Li N; Wu Y; Jia J; Suo T; Chen Q; Liu YJ; Tang J
PLoS One; 2011; 6(9):e24367. PubMed ID: 21931693
[TBL] [Abstract][Full Text] [Related]
8. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
9. The E3 ligase RNF185 negatively regulates osteogenic differentiation by targeting Dvl2 for degradation.
Zhou Y; Shang H; Zhang C; Liu Y; Zhao Y; Shuang F; Zhong H; Tang J; Hou S
Biochem Biophys Res Commun; 2014 May; 447(3):431-6. PubMed ID: 24727453
[TBL] [Abstract][Full Text] [Related]
10. The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope protein.
Zou C; Yoon H; Park PMC; Patten JJ; Pellman J; Carreiro J; Tsai JM; Li YD; Roy Burman SS; Donovan KA; Gasser J; Sperling AS; Nowak RP; Fischer ES; Davey RA; Ebert BL; Słabicki M
iScience; 2023 May; 26(5):106601. PubMed ID: 37095859
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
12. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.
Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M
J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response.
Wang Q; Huang L; Hong Z; Lv Z; Mao Z; Tang Y; Kong X; Li S; Cui Y; Liu H; Zhang L; Zhang X; Jiang L; Wang C; Zhou Q
PLoS Pathog; 2017 Mar; 13(3):e1006264. PubMed ID: 28273161
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
15. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
16. Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer.
Banyard J; Chung I; Migliozzi M; Phan DT; Wilson AM; Zetter BR; Bielenberg DR
BMC Cancer; 2014 May; 14():387. PubMed ID: 24885350
[TBL] [Abstract][Full Text] [Related]
17. Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer.
Le Hars M; Castro-Vega LJ; Rajabi F; Tabatadze D; Romero M; Pinskaya M; Groisman I
Biol Direct; 2023 Jul; 18(1):38. PubMed ID: 37434219
[TBL] [Abstract][Full Text] [Related]
18. RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma.
Liang RP; Zhang XX; Zhao J; Lu QW; Zhu RT; Wang WJ; Li J; Bo K; Zhang CX; Sun YL
World J Gastroenterol; 2022 Jul; 28(27):3435-3454. PubMed ID: 36158256
[TBL] [Abstract][Full Text] [Related]
19. The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.
Zhang X; Jing Y; Qin Y; Hunsucker S; Meng H; Sui J; Jiang Y; Gao L; An G; Yang N; Orlowski RZ; Yang L
Int J Biochem Cell Biol; 2012 Jul; 44(7):1166-73. PubMed ID: 22531714
[TBL] [Abstract][Full Text] [Related]
20. Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration.
Zhang A; Hitomi M; Bar-Shain N; Dalimov Z; Ellis L; Velpula KK; Fraizer GC; Gourdie RG; Lathia JD
Oncotarget; 2015 May; 6(13):11640-51. PubMed ID: 25960544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
